Searched for
ERIS LIFESCIENCES CMD
Stocks in news: IndiGo, Apollo Hospitals, Hyundai, TCS, NMDC, Laurus LabsApollo Hospitals' Hyderabad-based arm Apollo Health and Lifestyle Limited (AHLL) has acquired a controlling stake in Lucknow-based Care Dia...- Eris Lifesciences’ CMD Amit Bakshi buys luxury apartment in Mumbai’s Worli for Rs 61 croreBakshi has purchased the apartment spread over a carpet area of 64,50 sq ft on the 46th floor of the project from the developer, Oberoi Rea...
- Eris Lifesciences enters licensing deal with Biocon for insulin glargineThe launch of long acting insulin glargine will help Eris to fill the gap in its insulin portfolio. Eris derives more than half of its reve...
- With more visibility, the company would grow better in the future: Amit Bakshi, CMD, Eris LifescienceGlobal regulation has always been an impediment in the healthcare industry says Amit Bakshi, CMD, Eris Lifescience.
- Eris Lifesciences IPO price band will be at Rs 603: CMD Amit BakshiThe return ratios are quite astounding. Ex-cash return on capital as well as return on equity is in three digits, it is more than 100%.
- Eris Lifesciences sets IPO price band in Rs 600-603 rangeThe shareholders of the company plans to sell 28,875,000 equity shares.
- Tech Mahindra's Vineet Nayyar, Uday Kotak among many finalists for EY's Entrepreneur of the Year Award 2013Vineet Nayyar, C P Gurnani, Uday Kotak, V S S Mani are among the 17 finalists of EY's Entrepreneur Of The Year Awards, 2013.
Load More